Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Mortality in lupus nephritis.

J Karsh, J H Klippel, J E Balow

    Arthritis and Rheumatism
    |July 1, 1979
    PubMed
    Summary
    This summary is machine-generated.

    The main causes of death in lupus glomerulonephritis patients were renal failure, vascular events, and infections. Diffuse proliferative lupus glomerulonephritis increased renal failure risk, with early deaths from lupus/sepsis and late deaths from vascular issues.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    Collagenolytic activity of synovium in rheumatoid arthritis.

    The New England journal of medicine·2010
    Same author

    Treatment of type B insulin resistance: a novel approach to reduce insulin receptor autoantibodies.

    The Journal of clinical endocrinology and metabolism·2010
    Same author

    Cytotoxic responses to alloantigens in systemic lupus erythematosus.

    Journal of clinical immunology·2009
    Same author

    Is malignancy a major concern in rheumatoid arthritis patients?

    Journal of clinical rheumatology : practical reports on rheumatic & musculoskeletal diseases·2008
    Same author

    Predicting who will get lupus nephritis.

    Journal of clinical rheumatology : practical reports on rheumatic & musculoskeletal diseases·2008
    Same author

    Long-term effects of combination treatment with fludarabine and low-dose pulse cyclophosphamide in patients with lupus nephritis.

    Rheumatology (Oxford, England)·2007
    Same journal

    Proceedings of the Annual Meeting of the American Rheumatism Association.

    Arthritis and rheumatism·2020
    Same journal

    The regional distribution of rheumatologists: what can we do, what should we do?

    Arthritis and rheumatism·2013
    Same journal

    Regional distribution of adult rheumatologists.

    Arthritis and rheumatism·2013
    Same journal

    Clinically significant renal involvement in primary Sjögren's syndrome: clinical presentation and outcome.

    Arthritis and rheumatism·2013
    Same journal

    Headache in systemic lupus erythematosus: results from a prospective, international inception cohort study.

    Arthritis and rheumatism·2013
    Same journal

    Association of low baseline levels of erythrocyte folate with treatment nonresponse at three months in rheumatoid arthritis patients receiving methotrexate.

    Arthritis and rheumatism·2013
    See all related articles

    Area of Science:

    • Nephrology
    • Immunology
    • Pathology

    Background:

    • Lupus glomerulonephritis (LGN) is a severe autoimmune kidney disease.
    • Understanding mortality patterns in LGN is crucial for patient management.

    Purpose of the Study:

    • To review the principal causes of death in patients with lupus glomerulonephritis.
    • To identify associations between specific LGN subtypes and mortality causes.

    Main Methods:

    • Retrospective review of 68 patients diagnosed with lupus glomerulonephritis.
    • Analysis of causes of death, categorizing them into renal failure, vascular events, and infections.
    • Correlation of histological subtype (diffuse proliferative glomerulonephritis) with mortality patterns.

    Main Results:

    Related Experiment Videos

    • Renal failure was the leading cause of death (40%), followed by vascular events (25%) and infections (16%).
    • Diffuse proliferative glomerulonephritis showed a higher frequency of renal failure as a cause of death.
    • A bimodal mortality pattern was observed: early deaths from active lupus and sepsis, and late deaths from vascular events, alongside a constant rate of death from renal failure.

    Conclusions:

    • Renal failure, vascular events, and infections are the primary drivers of mortality in lupus glomerulonephritis.
    • Specific histological patterns, like diffuse proliferative glomerulonephritis, impact survival outcomes.
    • Timely interventions targeting lupus activity, infection, and cardiovascular risk are essential for improving prognosis.